Allianz Asset Management GmbH Sells 27,600 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Allianz Asset Management GmbH cut its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 53.8% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 23,700 shares of the company’s stock after selling 27,600 shares during the quarter. Allianz Asset Management GmbH’s holdings in Pediatrix Medical Group were worth $343,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Nomura Asset Management Co. Ltd. grew its position in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after buying an additional 1,220 shares in the last quarter. GAMMA Investing LLC increased its stake in Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after purchasing an additional 1,765 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company’s stock worth $98,000 after buying an additional 5,104 shares during the period. Squarepoint Ops LLC purchased a new position in shares of Pediatrix Medical Group in the fourth quarter valued at about $132,000. Finally, Sherbrooke Park Advisers LLC bought a new position in Pediatrix Medical Group during the 4th quarter valued at approximately $136,000. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Price Performance

MD stock opened at $11.98 on Friday. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 0.75. Pediatrix Medical Group, Inc. has a 52 week low of $7.47 and a 52 week high of $17.67. The company has a fifty day simple moving average of $13.43 and a two-hundred day simple moving average of $13.83. The firm has a market capitalization of $1.03 billion, a P/E ratio of -11.86 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The firm had revenue of $458.36 million during the quarter, compared to analyst estimates of $451.44 million. During the same quarter last year, the business earned $0.20 EPS. The business’s revenue was down 7.4% on a year-over-year basis. Analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on MD. Truist Financial decreased their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Macquarie lifted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Thursday, May 8th. Finally, UBS Group lowered their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a report on Monday, May 12th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus price target of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.